J&J in dock over medicine recalls
Source: Agencies |
January 16, 2011, Sunday
|
Print Edition
Print Edition
JOHNSON & Johnson faulted lax cleaning procedures and other problems at a manufacturing plant behind massive recalls of medicines like Tylenol, and said it was recalling nearly 50 million more bottles and packages of consumer medicines.
The healthcare company's reputation has been tarnished by repeated recalls totaling nearly 200 million bottles in the last year and it could face criminal charges from the US Department of Justice.
Johnson & Johnson is now recalling bottles and packages of various kinds of Tylenol, Benadryl, Rolaids and other consumer products. J&J said the new recall followed a review of records dating back to 2007 of products made by its McNeil consumer healthcare unit, which produces most of the recalled medicines sold in the United States.
While the company said it had identified a number of areas for improvement, on Friday it disclosed only the cleaning problem and a minor labeling irregularity.
The company investigation found insufficient equipment cleaning procedures and instances where people failed to adequately document cleaning at McNeil's Fort Washington, Pennsylvania plant.
J&J suspended production there last April.
Information
McNeil also found one product with a label that did not include all the information required by regulators, J&J said. The latest recall involved products affected by those issues, the company said, adding that it was "very unlikely" that this harmed product quality.
The company said it recalled nearly 43 million bottles of Tylenol 8 Hour, Tylenol Arthritis Pain, Tylenol Upper Respiratory, Benadryl, Sudafed PE and Sinutab.
Additionally, nearly 4 million bottles, rolls and packages of Rolaids were recalled.
The company last month recalled all batches of Softchews Rolaids produced by an outside manufacturer after people found wood and metal bits in the tablets. The recalls have kept popular products off drug store and supermarket shelves for months and hit the company's bottom line.
US sales of J&J consumer brands plunged 25 percent in the third quarter. It has begun to sell some of its brands, such as St. Joseph's aspirin, the subject of an earlier recall.
McNeil is conducting assessments at other manufacturing sites and will take whatever steps are needed, which could lead to more product recalls, J&J said.
Kurt Bardella, spokesman for Representative Darrell Issa, chairman of the House Committee on Oversight and Government reform, said Issa is seeking ways to ensure the US Food and Drug Administration can "better avoid a situation where a plant like in Fort Washington reaches this level of failure and uncertainty."
The healthcare company's reputation has been tarnished by repeated recalls totaling nearly 200 million bottles in the last year and it could face criminal charges from the US Department of Justice.
Johnson & Johnson is now recalling bottles and packages of various kinds of Tylenol, Benadryl, Rolaids and other consumer products. J&J said the new recall followed a review of records dating back to 2007 of products made by its McNeil consumer healthcare unit, which produces most of the recalled medicines sold in the United States.
While the company said it had identified a number of areas for improvement, on Friday it disclosed only the cleaning problem and a minor labeling irregularity.
The company investigation found insufficient equipment cleaning procedures and instances where people failed to adequately document cleaning at McNeil's Fort Washington, Pennsylvania plant.
J&J suspended production there last April.
Information
McNeil also found one product with a label that did not include all the information required by regulators, J&J said. The latest recall involved products affected by those issues, the company said, adding that it was "very unlikely" that this harmed product quality.
The company said it recalled nearly 43 million bottles of Tylenol 8 Hour, Tylenol Arthritis Pain, Tylenol Upper Respiratory, Benadryl, Sudafed PE and Sinutab.
Additionally, nearly 4 million bottles, rolls and packages of Rolaids were recalled.
The company last month recalled all batches of Softchews Rolaids produced by an outside manufacturer after people found wood and metal bits in the tablets. The recalls have kept popular products off drug store and supermarket shelves for months and hit the company's bottom line.
US sales of J&J consumer brands plunged 25 percent in the third quarter. It has begun to sell some of its brands, such as St. Joseph's aspirin, the subject of an earlier recall.
McNeil is conducting assessments at other manufacturing sites and will take whatever steps are needed, which could lead to more product recalls, J&J said.
Kurt Bardella, spokesman for Representative Darrell Issa, chairman of the House Committee on Oversight and Government reform, said Issa is seeking ways to ensure the US Food and Drug Administration can "better avoid a situation where a plant like in Fort Washington reaches this level of failure and uncertainty."
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
